Stable Cell Lines for Drug Screening in CNS

Innoprot assay development platform combinens both target-based and phenotypic screening due to their important role to move from in-vitro to in-vivo pharmacology for a high range of disease pathways. It can be directed toward the best detection technology for a given molecular target and screening objective.

Innoprot offers in vitro models for many diseases, including Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Laterial Sclerosis or Ischemic Stroke. These models mimick known pathways associated to each disease, allowing the screening of compounds of these diseases directly using of fluorescent microscopy analysis.

Explore our catalogue of cellular systems and find out what we can offer you!
Search
Categories
Innoprot
Privacy summary

This website uses cookies so that we can provide you with the best possible user experience. Cookie information is stored in your browser and performs functions such as recognising you when you return to our site or helping our team understand which parts of the site you find most interesting and useful.